Sam Chun Dang Pharm Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sam Chun Dang Pharm Co Ltd with three other
companies in this sector in KOREA (SOUTH) :
Celltrion Pharm Incorporated
sales of 173.51 billion Korean Won [US$149.22 million]
of which 38%
was Godex Cap),
JW Life Science Corp
(170.22 billion Korean Won [US$146.39 million]
Shin Poong Pharmaceutical Co., Ltd.
(189.72 billion Korean Won [US$163.16 million]
of which 73%
was Completed Medicine).
Sam Chun Dang Pharm Co Ltd reported sales of 186.60 billion Korean Won (US$160.48 million)
December of 2019.
increase of 16.7%
versus 2018, when the company's sales were 159.96 billion Korean Won .